| |
| |
|
| Insider
Information: |
Sharp Philip A |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
738,118 |
|
|
Indirect Shares
|
440,231 |
|
|
| Direct
Value |
$106,532,330 |
|
|
|
Indirect Value
|
$39,819,819 |
|
|
| Total
Shares |
1,178,349 |
|
|
| Total
Value |
$146,352,148 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
Director |
2009-06-03 |
470,278 |
2003-11-12 |
0 |
Premium* |
|
|
Alnylam Pharmaceuticals Inc |
ALNY |
Director |
2024-02-29 |
0 |
2024-02-29 |
266,899 |
Premium* |
|
|
Syros Pharmaceuticals, Inc. |
SYRS |
Director |
2016-07-06 |
146,666 |
2016-07-06 |
40,000 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2023-05-22 |
121,174 |
2023-05-22 |
133,332 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2003-11-12 |
4 |
A |
$0.00 |
$0 |
D/D |
828,000 |
828,000 |
|
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2004-05-14 |
4 |
S |
$58.41 |
$17,281,808 |
D/D |
(294,100) |
478,000 |
|
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2020-12-07 |
4 |
GA |
$0.00 |
$0 |
I/I |
235,633 |
266,899 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2020-12-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
235,633 |
0 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2008-09-23 |
4 |
GA |
$0.00 |
$0 |
I/I |
176,830 |
176,830 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2008-09-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
176,830 |
75,800 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2009-04-14 |
4 |
D |
$0.00 |
$0 |
I/I |
(176,830) |
0 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2009-04-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(176,830) |
75,800 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2009-04-14 |
4 |
A |
$0.00 |
$0 |
D/D |
176,830 |
252,630 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2009-04-14 |
4 |
A |
$0.00 |
$0 |
I/I |
176,830 |
176,830 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2016-07-06 |
4 |
A |
$0.00 |
$0 |
D/D |
146,666 |
146,666 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2019-10-16 |
4 |
A |
$0.00 |
$0 |
I/I |
133,332 |
44,444 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2016-07-06 |
4 |
A |
$0.00 |
$0 |
I/I |
120,000 |
40,000 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2014-10-13 |
4 |
AS |
$85.00 |
$9,350,000 |
D/D |
(110,000) |
74,996 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2014-10-13 |
4 |
OE |
$7.08 |
$847,800 |
D/D |
110,000 |
184,996 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2010-05-27 |
4 |
A |
$0.00 |
$0 |
I/I |
105,400 |
105,400 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2010-05-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(105,400) |
0 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2008-04-08 |
4 |
OE |
$35.42 |
$3,542,000 |
D/D |
100,000 |
515,983 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2019-10-16 |
4 |
A |
$0.00 |
$0 |
D/D |
88,888 |
105,368 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2008-04-08 |
4 |
AS |
$63.71 |
$4,976,151 |
D/D |
(76,850) |
489,133 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2008-07-21 |
4 |
AS |
$68.00 |
$4,930,000 |
D/D |
(72,500) |
468,033 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2008-07-21 |
4 |
OE |
$35.42 |
$2,567,950 |
D/D |
72,500 |
540,533 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2004-05-13 |
4 |
OE |
$11.73 |
$762,450 |
D/D |
65,000 |
65,000 |
|
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2004-05-13 |
4 |
S |
$58.00 |
$3,770,000 |
D/D |
(65,000) |
0 |
|
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2004-05-05 |
4/A |
S |
$59.00 |
$2,950,000 |
D/D |
(50,000) |
65,000 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
